| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.23 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |